Sign Out
There are no adequate data from the use of mesna in pregnant or lactating women. Physicians should carefully consider the potential risks and benefits for each specific patient before prescribing mesna.
Pregnancy and lactation are contraindications for cytostatic treatment, and consequently, Mesna is not likely to be used under these circumstances.
Should an individual patient be undergoing oxazaphosphorine therapy during pregnancy then Mesna should be administered to this patient.
Mothers should not breastfeed while being treated with these drugs.
Continue with Google